Pfizer Limited

Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone: +44 (0)1304 616 161
Fax: +44 (0)1304 656 221

Patient Information Leaflet last updated on the eMC: 21/12/2011
PIL Lipitor 10mg, 20mg, 40mg, 80mg Tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 21/12/2011 and displayed until Current
Reasons for adding or updating:
  • Introduction of new pack/pack size
Updated on 15/09/2011 and displayed until 21/12/2011
Reasons for adding or updating:
  • Change to MA holder contact details
  • Change to date of revision
  • Introduction of new pack/pack size
Updated on 08/03/2011 and displayed until 15/09/2011
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 23/11/2010 and displayed until 08/03/2011
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 22/10/2010 and displayed until 23/11/2010
Reasons for adding or updating:
  • Correction of spelling/typing errors
Updated on 12/10/2010 and displayed until 22/10/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to, or new, use for medicine
  • Change to side-effects
  • Change to dosage and administration
Updated on 01/06/2010 and displayed until 12/10/2010
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to appearance of the medicine
Updated on 13/04/2010 and displayed until 01/06/2010
Reasons for adding or updating:
  • Change of inactive ingredient
  • Change to appearance of the medicine
Updated on 23/12/2009 and displayed until 13/04/2010
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 30/11/2009 and displayed until 23/12/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 30/01/2009 and displayed until 30/11/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 15/01/2009 and displayed until 30/01/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
Updated on 06/08/2008 and displayed until 15/01/2009
Reasons for adding or updating:
  • Change to packaging
Updated on 23/04/2008 and displayed until 06/08/2008
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 25/02/2008 and displayed until 23/04/2008
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 06/11/2007 and displayed until 25/02/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
  • Change to Further Information section
  • Change to date of revision
Updated on 23/03/2007 and displayed until 06/11/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about overdose
  • Change to instructions about missed dose
  • Change to storage instructions
  • Change to side-effects
  • Change to drug interactions
  • Change to information about drinking alcohol
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to how the medicine works
  • Change to Further Information section
  • Change to date of revision
  • Change to dosage and administration
Updated on 11/05/2006 and displayed until 23/03/2007
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to date of revision
Updated on 06/01/2006 and displayed until 11/05/2006
Reasons for adding or updating:
  • Change of manufacturer
  • Change to warnings or special precautions for use
Updated on 19/04/2005 and displayed until 06/01/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to dosage and administration
  • Change to date of revision
Updated on 04/01/2005 and displayed until 19/04/2005
Reasons for adding or updating:
  • Change to drug interactions
  • Change to side-effects
  • Change to warnings or special precautions for use
Updated on 08/11/2004 and displayed until 04/01/2005
Reasons for adding or updating:
  • Change to drug interactions
Updated on 13/05/2003 and displayed until 08/11/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 11/09/2000 and displayed until 13/05/2003
Reasons for adding or updating:
  • No reasons supplied
Updated on 01/03/2000 and displayed until 11/09/2000
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   atorvastatin calcium trihydrate